Optimizing the Latest Advances for Managing Early Alzheimer’s Disease

Target Audience
This activity is designed to meet the educational needs of physicians and other healthcare professionals involved in the care of Alzheimer’s disease.

Program Overview
Make real-world decisions, answer challenging questions and assess expert guidance as you optimize diagnostic and therapeutic strategies for those facing issues potentially related to cognitive decline and early Alzheimer’ disease.

Topics addressed include:

Key clinical characteristics and risk factors for Alzheimer’s disease (AD)
Clinical factors and patient-centered considerations that guide decision-making
Diagnostic and therapeutic best practices and guidance
Benefit-risk profiles of available and late-stage investigational agents for early AD

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe key clinical characteristics and risk factors associated with Alzheimer’s disease (AD), and employ evidence-based tactics when diagnosing patients presenting with its symptoms
Compare clinical trial data, safety-efficacy profiles and target patient populations for approved and investigational agents for managing early AD
Individualize treatment decisions for patients with early AD, taking into consideration personal and clinical factors that may influence therapeutic response